While the rest of America was watching the Super Bowl, we were taking in the countryside in Montpellier, France, at first annual European Diabetes Technology and...

Several months after an FDA advisory committee delivered an overwhelmingly positive vote (20-2) in favor of approving Vivus’ Qnexa for the treatment of obesity, the...

Kerri Morrone Sparling advocates for unity in the diabetes community.

Insulet recently announced that its second-generation OmniPod had received approval in Europe. Compared to the first-generation OmniPod, the new pod is approximately 40...

Although insulin pens don't often grab headlines as much as other diabetes devices, we were glad to hear news about Novo Nordisk’s FlexTouch pen earlier this summer. The...

As we have previously written, Vivus’ weight loss drug Qnexa is up for approval in the US in April of this year. Encouragingly, Vivus announced recently that, if...

World Diabetes Day 2007 - Beautiful Landmarks for an Unrecognized Epidemic (B.L.U.E)

At the American Diabetes Association’s 71st annual Scientific Sessions held in late June in San Diego, we became excited about a number of therapies in development...

We always love attending the ADA Postgrad meeting – an update for doctors and nurses on new practices in diabetes.

In April, the FDA denied approval of the DPP-4 inhibitor alogliptin in the US. Takeda (the drug’s manufacturer) has not yet revealed the reasons behind the FDA’s...

Kerri Morrone Sparling reflects on the true meaning of ‘need’ in the global diabetes community…

On August 31, Abbott Diabetes Care announced that it will permanently discontinue the FreeStyle Navigator continuous glucose monitoring (CGM) system in the United States...

In late July, pharmacy benefit managers (PBMs) Express Scripts and Medco Health Solutions announced their plans to merge. As background, PBMs process prescriptions for...

Dr. Lawrence Soler writes a letter of concern to the New York Times .

Tandem Diabetes Care recently announced that its much anticipated t:slim insulin pump had received FDA clearance. This new pump features a color touchscreen and sleek...

Kelly’s take on the maddeningly slow FDA approval process and why things are probably getting better.

In late June, the European Medicines Agency (EMA) approved Amylin/Eli Lilly/Alkermes’ once-weekly injectable drug Bydureon for type 2 diabetes. We’ve been waiting for...

The 2007 AADE in August in St. Louis was extremely educational, as always.

Earlier in May, we were encouraged to hear that Dexcom has filed its new Gen 4 CGM sensor with the FDA. The review process typically takes six months or longer, meaning...

Diabetes on stage: Jim Hirsch tells us about Robbie McCauley’s powerful one-woman production, “Sugar."